Press Releases BBS-Bioactive Bone Substitutes Oyj

Equities

BONEH

FI4000260583

Market Closed - Nasdaq Helsinki Other stock markets 12:00:00 2024-07-05 pm EDT			5-day change	1st Jan Change
0.327 ^EUR	-5.49%		-7.63%	-33.13%

Jun. 13	BBS-Bioactive Bone Substitutes Oyj Approves Election of Gregor Siebert as New Member to the Board of Directors	CI
Jun. 04	BBS-Bioactive Bone Substitutes Plc Announces Approval of Complementary Patent Application for the ARTEBONE® Product	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BBS-Bioactive Bone Substitutes Plc has resolved on a share issue without consideration to the company itself	Jul. 02	AQ
BBS-Bioactive Bone Substitutes Plc: Notification pursuant to the Finnish Securities Market Act, Chapter 9, Section 10 - Municipality of Reisjärvi	Jun. 19	AQ
BBS-Bioactive Bone Substitutes Plc: Notification pursuant to the Finnish Securities Market Act, Chapter 9, Section 10 - Finha Capital Oy	Jun. 18	AQ
BBS-Bioactive Bone Substitutes Plc plans a share issue to strengthen its equity and will advance the publication date of its half-year report	Jun. 18	AQ
BBS-Bioactive Bone Substitutes Plc: Notification pursuant to the Finnish Securities Market Act, Chapter 9, Section 10 - Panvest Oy	Jun. 14	AQ
BBS-Bioactive Bone Substitutes Plc: Decisions of the Annual General Meeting 2024	Jun. 13	AQ
BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd	Jun. 05	AQ
BBS-Bioactive Bone Substitutes Plc: Claims of the complementary patent application for the ARTEBONE® product have been approved in the USA	Jun. 04	AQ
Notice to the BBS-Bioactive Bone Substitutes Plc’s Annual General Meeting	May. 23	AQ
BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd	May. 21	AQ
BBS-Bioactive Bone Substitutes Plc: Annual General Meeting in 2024	May. 07	AQ
BBS-Bioactive Bone Substitutes – Insider information: The company updates the status of the CE marking process	May. 05	AQ
BBS-Bioactive Bone Substitutes Plc: Annastiina Kauppinen appointed as Financial Manager of BBS-Bioactive Bone Substitutes Plc	Apr. 25	AQ
BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd	Apr. 24	AQ
BBS-Bioactive Bone Substitutes Plc: Annual General Meeting in 2024	Apr. 17	AQ
BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd	Apr. 15	AQ
BBS-Bioactive Bone Substitutes Plc: The website's functionality restored	Apr. 05	AQ
BBS-Bioactive Bone Substitutes Plc: Annual General Meeting in 2024	Apr. 03	AQ
BBS-Bioactive Bone Substitutes Plc: The website is under attack	Mar. 26	AQ
Correction: BBS-Bioactive Bone Substitutes Plc: Annual Report for 2023 has been published	Mar. 13	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases BBS-Bioactive Bone Substitutes Oyj

Equities

BONEH

FI4000260583

Press Releases

Filters